BEAT Director Strome Reports 60,483 RSUs and 36,364 Options
Rhea-AI Filing Summary
Mark E. Strome, a director of HeartBeam, Inc. (BEAT), reported transactions showing an indirect holding of 3,150,000 shares held by affiliated entities and a direct sale of 57,146 shares on 07/01/2025. The filing states Mr. Strome has authority to vote and dispose of the shares held by Strome Mezzanine Fund II, LP, Mark E. Strome Living Trust, and Strome Dynasty, LLC, and disclaims beneficial ownership except for his pecuniary interest.
The report also discloses equity awards: 60,483 restricted stock units granted on 07/11/2025 that vest on the earlier of 07/11/2026 or the 2026 annual meeting (subject to continued service as an Outside Director), and options covering 36,364 shares with an exercise price of $1.65 (granted 09/30/2025) and a vesting schedule tied to the July 1, 2025 commencement date. The filing is signed by Mr. Strome on 10/02/2025.
Positive
- 3,150,000 shares held indirectly by affiliated entities indicating significant stake
- 60,483 RSUs granted on 07/11/2025 that vest by 07/11/2026, aligning director pay with shareholders
- 36,364 options issued with an exercise price of $1.65, promoting long-term retention
Negative
- 57,146 shares were disposed of (sold) on 07/01/2025
Insights
Large indirect stake plus director awards indicate continued alignment with the company.
What it means: The report shows an indirect position of 3,150,000 shares controlled through affiliated vehicles while Mr. Strome also sold 57,146 shares on 07/01/2025. The disclosure that he has voting and dispositive authority over the entities is factual and typical for founder- or investor-affiliated holdings.
Why it matters: A sizeable indirect stake of 3.15M shares signals material ownership that can influence governance votes. The grant of 60,483 RSUs (vesting by 07/11/2026) and 36,364 options at $1.65 aligns the director’s compensation with equity performance and ties long-term retention to continued board service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Award | -- | -- | -- |
| holding | Common Stock (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The reported securities are held directly by Strome Mezzanine Fund II, LP, Mark E. Strome Living Trust and Strome Dynasty, LLC. Mr. Strome has the authority to vote and dispose of the reported securities held by each of these entities. Mr. Strome disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that Mr. Strome is a beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. These securities are restricted stock units (RSUs) granted on July 11, 2025. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 11, 2026, or the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date. RSUs do not expire, they either vest or are canceled prior to vesting date Granted options on September 30, 2025, one half of the total number of Shares subject to the Special Option shall vest on the three-month anniversary of the vesting commencement date (July 1, 2025) and the remaining Shares shall vest on the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.
